{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:16:32Z","timestamp":1791951392954,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2017-474"],"award-info":[{"award-number":["2017-474"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jaad.2018.08.053","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T12:38:14Z","timestamp":1537274294000},"page":"989-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features"],"prefix":"10.1016","volume":"81","author":[{"given":"Woo Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hee","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.08.053_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2018.08.053_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2018.08.053_bib4","first-page":"627","article-title":"Angioimmunoblastic lymphadenopathy with dysproteinemia","volume":"20","author":"Freter","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaad.2010.05.030","article-title":"Evaluation of cutaneous angioimmunoblastic T-cell lymphoma","volume":"65","author":"Balaraman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.053_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archderm.136.7.881","article-title":"Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis","volume":"136","author":"Martel","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.08.053_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.1993.tb00093.x","article-title":"Epstein-Barr virus in angioimmunoblastic T-cell lymphomas","volume":"22","author":"Khan","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2018.08.053_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)64770-0","article-title":"Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy","volume":"156","author":"Smith","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in\u00a0angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib11","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","article-title":"Heterogenous Epstein-Barr virus infection patterns in peripehral T-cell lymphoma of angioimmunoblastic lymphadenopathy type","volume":"80","author":"Anagnostopoulos","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a\u00a0spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3904\/kjim.2008.23.1.30","article-title":"Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma","volume":"23","author":"Lee","year":"2008","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jaad.2018.08.053_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4143\/crt.2017.476","article-title":"The prognostic role of circulating Epstein-Barr virus DNA copy number in angioimmunoblastic T-cell lymphoma treated with dose-adjusted EPOCH","volume":"51","author":"Liang","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.08.053_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1600-0560.2001.028008432.x","article-title":"Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression","volume":"28","author":"Brown","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib16","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0190-9622(79)70014-4","article-title":"Cutaneous manifestations of angioimmunoblastic lymphadenopathy","volume":"1","author":"Bernstein","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.053_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DAD.0000000000000144","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics","volume":"37","author":"Botros","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib20","first-page":"1192","article-title":"Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma","volume":"90","author":"Kawano","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2018.08.053_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ijc.20784","article-title":"Transactivation of the CCL5\/RANTES gene by Epstein-Barr virus latent membrane protein 1","volume":"114","author":"Uchihara","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.08.053_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000050055","article-title":"Role of interluekin-18 in peripheral blood mononuclear cells infected with human herpes virus type 6","volume":"44","author":"Arena","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.jaad.2018.08.053_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00277-012-1464-8","article-title":"Impact of the Epstein\u2013Barr virus positivity on Hodgkin's lymphoma in a large cohort from\u00a0a single institute in Korea","volume":"91","author":"Koh","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaad.2018.08.053_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hon.2468","article-title":"Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma","volume":"36","author":"Koh","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1096-9896(200002)190:2<143::AID-PATH519>3.0.CO;2-5","article-title":"Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease","volume":"190","author":"Dukers","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib27","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib28","first-page":"2429","article-title":"Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein\u2013Barr virus\u2013latent membrane protein 1 expression","volume":"90","author":"Morente","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428190009113386","article-title":"Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy","volume":"39","author":"Montalban","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2018.08.053_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1008337100424","article-title":"Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells","volume":"11","author":"Naresh","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/annonc\/mdg065","article-title":"The effect of Epstein\u2013Barr virus status on outcome in age- and sex defined subgroups of patients with advanced Hodgkin's disease","volume":"14","author":"Flavell","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.08.053_bib32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2018.08.053_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2141.2007.06620.x","article-title":"Angioimmunoblastic T-cell lymphoma: histological progression associated with EBV and HHV6B viral load","volume":"138","author":"Zhou","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2018.08.053_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/135965350400900313","article-title":"Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patients with angioimmunoblastic T-cell lymphoma","volume":"9","author":"Battegay","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jaad.2018.08.053_bib35","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.08.053_bib36","doi-asserted-by":"crossref","first-page":"e92585","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2018.08.053_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3324\/haematol.2011.061507","article-title":"Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA","volume":"97","author":"Delfau-Larue","year":"2012","journal-title":"Hematologica"},{"key":"10.1016\/j.jaad.2018.08.053_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coi.2009.05.009","article-title":"Effects of aging on T cell function","volume":"21","author":"Haynes","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2018.08.053_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.it.2009.05.004","article-title":"Human innate immunosenescence: causes and consequences for immunity in old age","volume":"30","author":"Panda","year":"2009","journal-title":"Trends Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:16Z","timestamp":1759272676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218325866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0190962218325866"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}